PAVM - PAVmed Inc logo

PAVmed Inc

PAVM

PAVmed Inc. develops and commercializes medical devices targeting unmet health needs. Key products include CarpX for carpal tunnel syndrome, EsoCheck for esophageal cancer screening, and PortIO, an implantable vascular access device.

โš•๏ธ Healthcare NASDAQ Listed 2016 $ USD
$1,000 invested 10 years ago โ†’$0today

Score Overview

1 Year
Scoreโ€”
Net Growthโ€”
Net Trendโ€”
Net Income Consistencyโ€”
Rev Growth57.75%
Rev TrendGrew
Revenue Consistencyโ€”
5 Years
Score5.5
Net Growth75.99%
Net Trend67%
Net Income Consistencyโ€”
Rev Growth-77.60%
Rev Trend60%
Revenue Consistencyโ€”
10 Years
Scoreโ€”
Net Growth-113.95%
Net Trend38%
Net Income Consistency
Rev Growthโ€”
Rev Trend40%
Revenue Consistency
All Time
Scoreโ€”
Net Growth-113.95%
Net Trend38%
Net Income Consistency
Rev Growthโ€”
Rev Trend40%
Revenue Consistency

Explore the 2021 public Archive ranking โ†’

Where PAVmed Inc has ranked, year by year

Measure
Fundamentals Window

Not enough ranking history to display a chart

This chart needs at least two years of available HDB Score rankings on 10 years of fundamentals. PAVM does not have enough ranked years in the public Archive through 2021.

More recent Archive years are available with Membership. Coverage varies by company and measure.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-10-22
$ 2.05โ€”
1 Year2025-10-22
$ 13.02-84.25%
5 Years2021-10-22
$ 2.22K-99.91%
10 Years2016-10-21
$ 4.6K-99.96%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Reported in USD

Year
TTM$ 112K-$ 12M$ 3M
2025$ 71K$ 1M
2024$ 2M$ 39M$ 1M
2023$ 2M-$ 64M$ 19M
2022$ 377K-$ 88M$ 42M
2021$ 500K-$ 50M$ 79M
2020$ 0.00-$ 34M$ 17M
2019$ 0.00-$ 15M$ 6M
2018$ 0.00-$ 17M$ 8M
2017$ 0.00-$ 9M$ 1M
IPO2016$ 0.00-$ 5M$ 585.68K
PAVM - PAVmed Inc logo

PAVmed Inc fundamental performance

Between 2020 and 2025, revenue grew from $ 0.00 to $ 71K. Revenue increased in 3 of those 5 years; net income in 3.

PAVmed Inc currently holds a 5-year HDB Score of 5.5 out of 10. How the HDB Score is calculated.

Membership

Explore PAVM with current data

The public Archive runs through 2021. Membership adds recent and current rankings.

  • Recent and current rankings across 5,119 companies
  • Compare companies with the latest data
  • Track your research shortlist in a portfolio

$99 / year

$149/year ยท Founding price

Continue with Membership

30-day money-back guarantee.

Explore other companies